Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Apple
AAPL
|
$2.62B |
| 2 |
McDonald's
MCD
|
$1.21B |
| 3 |
Progressive
PGR
|
$1.13B |
| 4 |
Exelon
EXC
|
$981M |
| 5 |
Pfizer
PFE
|
$744M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.68B |
| 2 |
MDCO
Medicines Co
MDCO
|
$903M |
| 3 |
Boston Scientific
BSX
|
$781M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$636M |
| 5 |
Nike
NKE
|
$595M |
Sector Composition
| 1 | Healthcare | 22.74% |
| 2 | Financials | 15.42% |
| 3 | Technology | 14.93% |
| 4 | Industrials | 10.78% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
W.P. Carey
WPC
$14.9B
| $718K | ﹤0.01% |
9,156
+1,723
| +23% | +$135K |
|
|
CMD
1752
DELISTED
Cantel Medical Corporation
CMD
| $718K | ﹤0.01% |
10,129
-12,393
| -55% | -$878K |
|
1753
10x Genomics
TXG
$1.74B
| $699K | ﹤0.01% |
9,169
-66,458
| -88% | -$5.07M |
|
|
DISCA
1754
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $696K | ﹤0.01% |
21,254
-123,615
| -85% | -$4.05M |
|
1755
Constellium
CSTM
$2.04B
| $695K | ﹤0.01% |
51,858
+36,433
| +236% | +$488K |
|
1756
FibroGen
FGEN
$48.9M
| $693K | ﹤0.01% |
647
+129
| +25% | +$138K |
|
1757
First Business Financial Services
FBIZ
$433M
| $691K | ﹤0.01% |
26,243
-4,308
| -14% | -$113K |
|
|
DEA
1758
Easterly Government Properties
DEA
$1.05B
| $689K | ﹤0.01% |
11,610
+1,608
| +16% | +$95.4K |
|
|
ENV
1759
DELISTED
ENVESTNET, INC.
ENV
| $688K | ﹤0.01% |
9,888
-8,638
| -47% | -$601K |
|
1760
Asbury Automotive
ABG
$5.06B
| $676K | ﹤0.01% |
6,046
-2,519
| -29% | -$282K |
|
1761
Atkore
ATKR
$1.99B
| $676K | ﹤0.01% |
16,723
-5,498
| -25% | -$222K |
|
1762
Bloomin' Brands
BLMN
$605M
| $671K | ﹤0.01% |
+30,403
| New | +$671K |
|
1763
Royal Caribbean
RCL
$95.7B
| $665K | ﹤0.01% |
4,982
-278,204
| -98% | -$37.1M |
|
1764
NeoGenomics
NEO
$1.03B
| $664K | ﹤0.01% |
22,696
-86,062
| -79% | -$2.52M |
|
1765
Editas Medicine
EDIT
$248M
| $660K | ﹤0.01% |
+22,299
| New | +$660K |
|
|
PLAN
1766
DELISTED
Anaplan, Inc.
PLAN
| $649K | ﹤0.01% |
+12,377
| New | +$649K |
|
1767
Graco
GGG
$14.2B
| $648K | ﹤0.01% |
12,465
-101,394
| -89% | -$5.27M |
|
1768
B. Riley Financial
RILY
$152M
| $645K | ﹤0.01% |
25,623
-748
| -3% | -$18.8K |
|
1769
Esperion Therapeutics
ESPR
$540M
| $642K | ﹤0.01% |
+10,773
| New | +$642K |
|
1770
Tractor Supply
TSCO
$32.1B
| $640K | ﹤0.01% |
34,235
-105,815
| -76% | -$1.98M |
|
|
EPZM
1771
DELISTED
Epizyme, Inc
EPZM
| $636K | ﹤0.01% |
+25,869
| New | +$636K |
|
1772
Graham Holdings Company
GHC
$4.93B
| $634K | ﹤0.01% |
993
-2,012
| -67% | -$1.28M |
|
1773
Bank of Hawaii
BOH
$2.72B
| $630K | ﹤0.01% |
+6,622
| New | +$630K |
|
|
MNR
1774
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $624K | ﹤0.01% |
43,092
-1,257
| -3% | -$18.2K |
|
1775
iShares Core S&P 500 ETF
IVV
$664B
| $622K | ﹤0.01% |
1,925
| – | – |
|